Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy
- Autores
- Velez, Eva Maria del Mar; Maldonado, Natalia Cecilia; Carmuega, E.; Weil, R.; Perdigon, Gabriela del Valle
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Intestinal microbiota has an essential role in the maturation and function of the immune system. Changes in the microbiota, together withgenetic factors induce the development of allergy with a typical Th2 profile(1). Several studies have shown that probiotics have a beneficialeffect in disease and can stimulate the mucosal immune system by improving microbiota composition(2); hence, probiotics oral admin-istration is proposed to avoid the allergy development by balancing microbiota and modulating the immune system, not only at theintestinal mucosa, but also in other mucosal sites and at systemic level(3). This study was aimed to evaluate the adjuvant immune effect ofthe oral administration of a probiotic fermented milk (PFM) in the intestinal mucosa and the extent of these effects on distant mucosalsites (bronchus) in an experimental mouse model of allergic airway reactivity to ovoalbumin (OVA). Experimental groups: normal-control(NC), Basal (B-5days-PFM); OVA-Sensitization-control (SC), Previous (P) (5d-PFM +OVA +H2O) and Continuous (C) (5d-PFM +OVA +PFM). SC, P and C were sensitized with OVA 1 % followed by daily exposures to OVA aerosols. At 7 and 15 days post-sensitization (dPS) specific-IgE, specific-IgG and IL-10 in serum, total S-IgA, IL-10 and IFN-gin intestinal fluid (IF), specific-IgE inbronchoalveolar lavage (BAL) were determined by ELISA. The number of IgA +, IL-10 +and IL-4 +cells in the lamina propria of smallintestine (SI) and lungs were determined by immunofluorescense assay. In large intestine (LI) total populations of total anaerobes,lactobacilli, bifidobacteria and enterobacteria in selective media were determined. Specific-IgE was reduced in treated groups with regardto SC in serum and BAL (DO 450nm) (Table 1). Specific-IgG increased in all groups but showed the highest values in C (Table 2).Table 1. Anti OVA IgE in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.08°0.01 0.09°0.017 dPS 0.87°0.07 0.38°0.13 0.38°0.01215 dPS 0.47°0.02 0.47°0.01 0.31°0.06Table 2. Anti OVA IgG in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.06°0.01 0.08°0.037 dPS 0.78°0.01 0.80°0.05 1,03°0.0715 dPS 0.67°0.06 0.65°0.13 0.92°0.10IL-10 values increased in SC in SI fluid compared to treated groups, with no changes in serum. Total S-IgA from SI fluid significantlyincreased in CS and P compared to NC, B and C. IL-4 +cells increased significantly in SC in lungs compared to the other groups at 7 and15 dPS; in SI no differences were found between controls and treated groups. The number of IL-10 +cells was significantly higher in thelamina propria of SI from SC group compared to P and C at 7 and 15 dPS. PFM induced a decrease of enterobacteria and increase ofbifidobacteria only in C, other populations were not affected. PFM reduced specific-IgE levels in serum and BAL in mice with continuoustreatment; this could be mediated by intestinal microbiota regulation that might have influence on the expression of cytokines IL-4(Th2 type) and IL-10 (regulatory cytokine) at the mucosal level (intestine and lungs). However systemic and mucosal normal immuneresponse was not affected because IgG and S-IgA production was not altered by IL-10.1. Bjorksten B, Sepp E, Julge K et al. (2001) J Allergy Clin Immunol 108, 516?520.2. Galdeano CM & Perdigon G (2006) Clin Vaccine Immunol 13, 219?226.3. de Moreno de LeBlanc A, Maldonado Galdeano C, Chaves, S and Perdigon, G. (2005) Eur J Inflamm 3, 25?30.
Fil: Velez, Eva Maria del Mar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Maldonado, Natalia Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; Argentina
Fil: Carmuega, E.. Nutritia; Argentina
Fil: Weil, R.. DANONE; Argentina
Fil: Perdigon, Gabriela del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; Argentina - Materia
-
Probioticos
Sistema Inmune
Alergia - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/70944
Ver los metadatos del registro completo
id |
CONICETDig_d6bc53505cb4a5376af040edad2e7fb4 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/70944 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergyVelez, Eva Maria del MarMaldonado, Natalia CeciliaCarmuega, E.Weil, R.Perdigon, Gabriela del ValleProbioticosSistema InmuneAlergiahttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Intestinal microbiota has an essential role in the maturation and function of the immune system. Changes in the microbiota, together withgenetic factors induce the development of allergy with a typical Th2 profile(1). Several studies have shown that probiotics have a beneficialeffect in disease and can stimulate the mucosal immune system by improving microbiota composition(2); hence, probiotics oral admin-istration is proposed to avoid the allergy development by balancing microbiota and modulating the immune system, not only at theintestinal mucosa, but also in other mucosal sites and at systemic level(3). This study was aimed to evaluate the adjuvant immune effect ofthe oral administration of a probiotic fermented milk (PFM) in the intestinal mucosa and the extent of these effects on distant mucosalsites (bronchus) in an experimental mouse model of allergic airway reactivity to ovoalbumin (OVA). Experimental groups: normal-control(NC), Basal (B-5days-PFM); OVA-Sensitization-control (SC), Previous (P) (5d-PFM +OVA +H2O) and Continuous (C) (5d-PFM +OVA +PFM). SC, P and C were sensitized with OVA 1 % followed by daily exposures to OVA aerosols. At 7 and 15 days post-sensitization (dPS) specific-IgE, specific-IgG and IL-10 in serum, total S-IgA, IL-10 and IFN-gin intestinal fluid (IF), specific-IgE inbronchoalveolar lavage (BAL) were determined by ELISA. The number of IgA +, IL-10 +and IL-4 +cells in the lamina propria of smallintestine (SI) and lungs were determined by immunofluorescense assay. In large intestine (LI) total populations of total anaerobes,lactobacilli, bifidobacteria and enterobacteria in selective media were determined. Specific-IgE was reduced in treated groups with regardto SC in serum and BAL (DO 450nm) (Table 1). Specific-IgG increased in all groups but showed the highest values in C (Table 2).Table 1. Anti OVA IgE in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.08°0.01 0.09°0.017 dPS 0.87°0.07 0.38°0.13 0.38°0.01215 dPS 0.47°0.02 0.47°0.01 0.31°0.06Table 2. Anti OVA IgG in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.06°0.01 0.08°0.037 dPS 0.78°0.01 0.80°0.05 1,03°0.0715 dPS 0.67°0.06 0.65°0.13 0.92°0.10IL-10 values increased in SC in SI fluid compared to treated groups, with no changes in serum. Total S-IgA from SI fluid significantlyincreased in CS and P compared to NC, B and C. IL-4 +cells increased significantly in SC in lungs compared to the other groups at 7 and15 dPS; in SI no differences were found between controls and treated groups. The number of IL-10 +cells was significantly higher in thelamina propria of SI from SC group compared to P and C at 7 and 15 dPS. PFM induced a decrease of enterobacteria and increase ofbifidobacteria only in C, other populations were not affected. PFM reduced specific-IgE levels in serum and BAL in mice with continuoustreatment; this could be mediated by intestinal microbiota regulation that might have influence on the expression of cytokines IL-4(Th2 type) and IL-10 (regulatory cytokine) at the mucosal level (intestine and lungs). However systemic and mucosal normal immuneresponse was not affected because IgG and S-IgA production was not altered by IL-10.1. Bjorksten B, Sepp E, Julge K et al. (2001) J Allergy Clin Immunol 108, 516?520.2. Galdeano CM & Perdigon G (2006) Clin Vaccine Immunol 13, 219?226.3. de Moreno de LeBlanc A, Maldonado Galdeano C, Chaves, S and Perdigon, G. (2005) Eur J Inflamm 3, 25?30.Fil: Velez, Eva Maria del Mar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Maldonado, Natalia Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; ArgentinaFil: Carmuega, E.. Nutritia; ArgentinaFil: Weil, R.. DANONE; ArgentinaFil: Perdigon, Gabriela del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; ArgentinaCambridge University Press2013-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/70944Velez, Eva Maria del Mar; Maldonado, Natalia Cecilia; Carmuega, E.; Weil, R.; Perdigon, Gabriela del Valle; Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy; Cambridge University Press; Proceedings Of The Nutrition Society; 72; OCE1; 4-20130029-6651CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.journals.cambridge.org/abstract_S002966511300058Xinfo:eu-repo/semantics/altIdentifier/doi/10.1017/S002966511300058Xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:25:07Zoai:ri.conicet.gov.ar:11336/70944instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:25:07.977CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
title |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
spellingShingle |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy Velez, Eva Maria del Mar Probioticos Sistema Inmune Alergia |
title_short |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
title_full |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
title_fullStr |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
title_full_unstemmed |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
title_sort |
Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy |
dc.creator.none.fl_str_mv |
Velez, Eva Maria del Mar Maldonado, Natalia Cecilia Carmuega, E. Weil, R. Perdigon, Gabriela del Valle |
author |
Velez, Eva Maria del Mar |
author_facet |
Velez, Eva Maria del Mar Maldonado, Natalia Cecilia Carmuega, E. Weil, R. Perdigon, Gabriela del Valle |
author_role |
author |
author2 |
Maldonado, Natalia Cecilia Carmuega, E. Weil, R. Perdigon, Gabriela del Valle |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Probioticos Sistema Inmune Alergia |
topic |
Probioticos Sistema Inmune Alergia |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Intestinal microbiota has an essential role in the maturation and function of the immune system. Changes in the microbiota, together withgenetic factors induce the development of allergy with a typical Th2 profile(1). Several studies have shown that probiotics have a beneficialeffect in disease and can stimulate the mucosal immune system by improving microbiota composition(2); hence, probiotics oral admin-istration is proposed to avoid the allergy development by balancing microbiota and modulating the immune system, not only at theintestinal mucosa, but also in other mucosal sites and at systemic level(3). This study was aimed to evaluate the adjuvant immune effect ofthe oral administration of a probiotic fermented milk (PFM) in the intestinal mucosa and the extent of these effects on distant mucosalsites (bronchus) in an experimental mouse model of allergic airway reactivity to ovoalbumin (OVA). Experimental groups: normal-control(NC), Basal (B-5days-PFM); OVA-Sensitization-control (SC), Previous (P) (5d-PFM +OVA +H2O) and Continuous (C) (5d-PFM +OVA +PFM). SC, P and C were sensitized with OVA 1 % followed by daily exposures to OVA aerosols. At 7 and 15 days post-sensitization (dPS) specific-IgE, specific-IgG and IL-10 in serum, total S-IgA, IL-10 and IFN-gin intestinal fluid (IF), specific-IgE inbronchoalveolar lavage (BAL) were determined by ELISA. The number of IgA +, IL-10 +and IL-4 +cells in the lamina propria of smallintestine (SI) and lungs were determined by immunofluorescense assay. In large intestine (LI) total populations of total anaerobes,lactobacilli, bifidobacteria and enterobacteria in selective media were determined. Specific-IgE was reduced in treated groups with regardto SC in serum and BAL (DO 450nm) (Table 1). Specific-IgG increased in all groups but showed the highest values in C (Table 2).Table 1. Anti OVA IgE in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.08°0.01 0.09°0.017 dPS 0.87°0.07 0.38°0.13 0.38°0.01215 dPS 0.47°0.02 0.47°0.01 0.31°0.06Table 2. Anti OVA IgG in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.06°0.01 0.08°0.037 dPS 0.78°0.01 0.80°0.05 1,03°0.0715 dPS 0.67°0.06 0.65°0.13 0.92°0.10IL-10 values increased in SC in SI fluid compared to treated groups, with no changes in serum. Total S-IgA from SI fluid significantlyincreased in CS and P compared to NC, B and C. IL-4 +cells increased significantly in SC in lungs compared to the other groups at 7 and15 dPS; in SI no differences were found between controls and treated groups. The number of IL-10 +cells was significantly higher in thelamina propria of SI from SC group compared to P and C at 7 and 15 dPS. PFM induced a decrease of enterobacteria and increase ofbifidobacteria only in C, other populations were not affected. PFM reduced specific-IgE levels in serum and BAL in mice with continuoustreatment; this could be mediated by intestinal microbiota regulation that might have influence on the expression of cytokines IL-4(Th2 type) and IL-10 (regulatory cytokine) at the mucosal level (intestine and lungs). However systemic and mucosal normal immuneresponse was not affected because IgG and S-IgA production was not altered by IL-10.1. Bjorksten B, Sepp E, Julge K et al. (2001) J Allergy Clin Immunol 108, 516?520.2. Galdeano CM & Perdigon G (2006) Clin Vaccine Immunol 13, 219?226.3. de Moreno de LeBlanc A, Maldonado Galdeano C, Chaves, S and Perdigon, G. (2005) Eur J Inflamm 3, 25?30. Fil: Velez, Eva Maria del Mar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Maldonado, Natalia Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; Argentina Fil: Carmuega, E.. Nutritia; Argentina Fil: Weil, R.. DANONE; Argentina Fil: Perdigon, Gabriela del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Microbiología; Argentina |
description |
Intestinal microbiota has an essential role in the maturation and function of the immune system. Changes in the microbiota, together withgenetic factors induce the development of allergy with a typical Th2 profile(1). Several studies have shown that probiotics have a beneficialeffect in disease and can stimulate the mucosal immune system by improving microbiota composition(2); hence, probiotics oral admin-istration is proposed to avoid the allergy development by balancing microbiota and modulating the immune system, not only at theintestinal mucosa, but also in other mucosal sites and at systemic level(3). This study was aimed to evaluate the adjuvant immune effect ofthe oral administration of a probiotic fermented milk (PFM) in the intestinal mucosa and the extent of these effects on distant mucosalsites (bronchus) in an experimental mouse model of allergic airway reactivity to ovoalbumin (OVA). Experimental groups: normal-control(NC), Basal (B-5days-PFM); OVA-Sensitization-control (SC), Previous (P) (5d-PFM +OVA +H2O) and Continuous (C) (5d-PFM +OVA +PFM). SC, P and C were sensitized with OVA 1 % followed by daily exposures to OVA aerosols. At 7 and 15 days post-sensitization (dPS) specific-IgE, specific-IgG and IL-10 in serum, total S-IgA, IL-10 and IFN-gin intestinal fluid (IF), specific-IgE inbronchoalveolar lavage (BAL) were determined by ELISA. The number of IgA +, IL-10 +and IL-4 +cells in the lamina propria of smallintestine (SI) and lungs were determined by immunofluorescense assay. In large intestine (LI) total populations of total anaerobes,lactobacilli, bifidobacteria and enterobacteria in selective media were determined. Specific-IgE was reduced in treated groups with regardto SC in serum and BAL (DO 450nm) (Table 1). Specific-IgG increased in all groups but showed the highest values in C (Table 2).Table 1. Anti OVA IgE in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.08°0.01 0.09°0.017 dPS 0.87°0.07 0.38°0.13 0.38°0.01215 dPS 0.47°0.02 0.47°0.01 0.31°0.06Table 2. Anti OVA IgG in serum (Absorbance, DO 450 nm) (media°SD)NC B SC P C5 dPFM 0.06°0.01 0.08°0.037 dPS 0.78°0.01 0.80°0.05 1,03°0.0715 dPS 0.67°0.06 0.65°0.13 0.92°0.10IL-10 values increased in SC in SI fluid compared to treated groups, with no changes in serum. Total S-IgA from SI fluid significantlyincreased in CS and P compared to NC, B and C. IL-4 +cells increased significantly in SC in lungs compared to the other groups at 7 and15 dPS; in SI no differences were found between controls and treated groups. The number of IL-10 +cells was significantly higher in thelamina propria of SI from SC group compared to P and C at 7 and 15 dPS. PFM induced a decrease of enterobacteria and increase ofbifidobacteria only in C, other populations were not affected. PFM reduced specific-IgE levels in serum and BAL in mice with continuoustreatment; this could be mediated by intestinal microbiota regulation that might have influence on the expression of cytokines IL-4(Th2 type) and IL-10 (regulatory cytokine) at the mucosal level (intestine and lungs). However systemic and mucosal normal immuneresponse was not affected because IgG and S-IgA production was not altered by IL-10.1. Bjorksten B, Sepp E, Julge K et al. (2001) J Allergy Clin Immunol 108, 516?520.2. Galdeano CM & Perdigon G (2006) Clin Vaccine Immunol 13, 219?226.3. de Moreno de LeBlanc A, Maldonado Galdeano C, Chaves, S and Perdigon, G. (2005) Eur J Inflamm 3, 25?30. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/70944 Velez, Eva Maria del Mar; Maldonado, Natalia Cecilia; Carmuega, E.; Weil, R.; Perdigon, Gabriela del Valle; Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy; Cambridge University Press; Proceedings Of The Nutrition Society; 72; OCE1; 4-2013 0029-6651 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/70944 |
identifier_str_mv |
Velez, Eva Maria del Mar; Maldonado, Natalia Cecilia; Carmuega, E.; Weil, R.; Perdigon, Gabriela del Valle; Immune modulation promoted by probiotic fermented milk in the mucosal immune system in an experimental model of allergy; Cambridge University Press; Proceedings Of The Nutrition Society; 72; OCE1; 4-2013 0029-6651 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.journals.cambridge.org/abstract_S002966511300058X info:eu-repo/semantics/altIdentifier/doi/10.1017/S002966511300058X |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Cambridge University Press |
publisher.none.fl_str_mv |
Cambridge University Press |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614249368780800 |
score |
13.070432 |